Chemgenix Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.19 Cr
as on 22-08-2024
- Paid Up Capital ₹ 1.19 Cr
as on 22-08-2024
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.35 Cr
as on 22-08-2024
- Revenue -61.17%
(FY 2023)
- Profit -87.60%
(FY 2023)
- Ebitda -0.29%
(FY 2023)
- Net Worth 2.48%
(FY 2023)
- Total Assets -73.54%
(FY 2023)
About Chemgenix Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.19 Cr and a paid-up capital of Rs 1.19 Cr.
The company currently has active open charges totaling ₹2.35 Cr.
Nitin Panchagnula and Premalatha Bhaskara serve as directors at the Company.
- CIN/LLPIN
U52190TG2016PTC111232
- Company No.
111232
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Aug 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Chemgenix Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitin Panchagnula  | Additional Director | 25-Oct-2018 | Current |
| Premalatha Bhaskara | Director | 01-Aug-2016 | Current |
Financial Performance of Chemgenix Laboratories.
Chemgenix Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 61.17% decrease. The company also saw a substantial fall in profitability, with a 87.6% decrease in profit. The company's net worth moved up by a moderate rise of 2.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chemgenix Laboratories?
Unlock access to Chemgenix Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 10 Jan 2022 | ₹1.03 Cr | Open |
Axis Bank Limited Creation Date: 10 Jan 2022 | ₹4.70 M | Open |
Others Creation Date: 01 Jul 2020 | ₹8.50 M | Open |
How Many Employees Work at Chemgenix Laboratories?
Unlock and access historical data on people associated with Chemgenix Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemgenix Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemgenix Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
